TickerFacts.

UL Solutions Inc. (ULS): Shareholders' Equity

Annual figures by period end, from SEC filings.

$1.29B
As of 2025-12-31
$1.62B
As of 2026-06-30
+6.3%
3-year compound annual growth
2022-12-31: $1.08B2023-12-31: $678.00M2024-12-31: $931.00M2025-12-31: $1.29B$1.29B
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$1.29B+39.0%2026-02-19, Balance as of period end
2024-12-31$931.00M+37.3%2026-02-19, Balance as of period end
2023-12-31$678.00M-37.0%2026-02-19, Balance as of period end
2022-12-31$1.08Bn/a2025-02-20, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
UL Solutions Inc. (ULS)2025-12-31$1.29B+39.0%
NeoGenomics Inc (NEO)2025-12-31$836.56M-7.3%
20/20 Biolabs, Inc. (AIDX)2025-12-31-$19.2Kn/m
Hypha Labs, Inc. (FUNI)2025-09-30-$2.44Mn/m

Compare ULS, NEO, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗